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in the Golgi apparatus and translocates to the
spindle apparatus during mitosis
Sandra Lührig, Susanne Kolb, Nadine Mellies and Jessica Nolte*Abstract
Proteins of the BTB-kelch family are known to be involved in multiple biological processes such as migration,
cytoskeleton arrangement, regulation of cell morphology, protein ubiquitination and gene expression. KBTBD8 is a
new member of this family. The gene was found in a comparative transcriptome analysis of pluripotent stem cells
and was therefore suggested to play a role in the regulation of pluripotency. Comparative analysis of the gene
and protein sequences revealed a high conservation throughout evolution especially in the characteristic domains
of BTB, BACK and kelch. We identified the Golgi apparatus as the subcellular localization of the KBTBD8 protein in
non-dividing cells and could show that KBTBD8 co-localizes with α-tubulin on the spindle apparatus of mitotic
cells suggesting a role in cell proliferation. In conclusion, KBTBD8 is a new member of the BTB-kelch superfamily
that is located in the Golgi apparatus and translocates to the spindle apparatus during mitosis.
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In a comparative study of the transcriptomes of mouse
pluripotent Embryonic Stem Cells (ESCs) and multipotent
adult Germline Stem Cells (maGSCs) [1], Kbtbd8 (kelch
repeat and BTB (POZ) domain containing 8) was found to
be highly expressed in undifferentiated and differentiated
stem cells. Therefore we suggested that the unknown gene
Kbtbd8 might play a role in pluripotency. The analysis of
the gene and protein structure revealed KBTBD8 as a
member of the BTB-kelch family of proteins. It is highly
conserved through evolution and the protein consists of a
BTB/POZ domain, a BACK domain and five kelch repeats
(Figure 1).
The BTB/POZ domain was first identified in Drosophila
melanogaster. It displays a conserved motif found in many
bric-á-brac, tramtrack and complex transcriptional regula-
tors as well as in several pox virus zink finger proteins
[2-4]. There are five subfamilies of kelch-repeat family
known and Kbtbd8 can be classified as a member of the
“N-dimer, C-propeller” subfamily [5]. These proteins con-
tain the BTB/POZ domain at the N-terminus and four to* Correspondence: jnolte1@gwdg.de
Institute of Human Genetics, University of Göttingen, Göttingen 37073,
Germany
© 2013 Lührig et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orsix kelch motifs at the C-terminus. Furthermore KBTBD8,
as most of the BTB-kelch proteins, also contains a
carboxyterminal kelch, a BACK domain (Figure 1). Pro-
teins belonging to this subtype are also known as BBK
(BTB, BACK, kelch) proteins [6]. The BTB domain in these
proteins has been shown to be responsible for protein di-
merisation and oligomerization in accordance to the often
found function of actin filament organisation [7-10]. The
ENC-1 protein was shown to be an actin-binding protein
that is involved in the organization of the actin cytoskel-
eton [11], gigaxonin was shown to serve as a functional
link between the intermediate filaments of the cytoskeleton
and actin filaments [12]. Despite the connection to the
actin cytoskeleton, several other functions of members of
the BTB-kelch family are known. Keap1 for instance was
shown to be a transcriptional regulator by directly binding
the transcription factor Nrf2 via its Kelch-repeats [13]. The
function of BTB-kelch proteins in regulation of transcrip-
tion was further supported by the finding that two BTB
proteins directly interact with topoisomerase I, even
though a direct regulation of the enzyme activity could not
be demonstrated [14]. Geyer et al. [15] identified BTB/
POZ proteins in yeast as components of ubiquitin ligase
complexes. This was supported by the results of otherLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Structure of KBTBD8 protein. A: Comparison of the amino acid sequences of mouse and human KBTBD8 protein including domain
structures. Amino acid sequence of mouse and human KBTBD8 protein shows a 95% homology. Both consist of five kelch motifs (orange) at the
N-terminal part of the protein. The C-terminal part has a BTB/POZ-domain (purple) followed by a BACK-domain (red). Asterisk (*) indicates
positions which have a single, fully conserved residue. Colon (:) indicates conservation between groups of strongly similar properties. Period (.)
indicates conservation between groups of weakly similar properties. B: Domain structure of mouse KBTBD8 protein including the depiction of
amino acid position.
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kelch proteins play an important role in multiple biological
processes, are highly conserved and therefore seem to be
important even in evolution.
To date there is only one member of this family known
that is located in the Golgi apparatus. The BTB-kelch
protein “leucin zipper-like transcriptional regulator 1”
(LZTR-1) was first found to be hemizygously deleted inDiGeorge syndrome patients [19]. In 2006, Nacak et al.
[20] characterized LZTR-1 on the molecular level and
found the protein to be Golgi-matrix associated. Further
analysis revealed that the BTB domain is responsible for
this association.
Here we have characterized another BBK family mem-
ber and show that KBTBD8 is specifically localized at
the Golgi in non dividing cells and becomes restricted to
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this is the first time that a BBK family member is shown
to be trapped in the Golgi and becomes translocated to
the forming spindle apparatus upon mitosis.
Results
Expression analysis of mouse and human KBTBD8
Mouse Kbtbd8 is located on chromosome 6 and is pre-
dicted to have two protein coding transcripts. Transcript
one consists of 4 exons, transcript 2 is lacking exons 1
and 2 (Additional file 1: Figure S1). This leads to a trun-
cated BTB/POZ domain of the isoform b. The open
reading frame (ORF) of the full length isoform is
1801 bp in size and encodes a 599 AA protein with a
predicted size of 68.6 kDa. The ORF of the shorter tran-
script is 1569 bp in size and encodes a 522 AA protein
with a predicted size of 60.4 kDa. Human KBTBD8 is lo-
cated on the short arm of chromosome 3, consists of 4
exons and the ORF of 4684 bp encodes for a 601 AA
protein with a predicted size of 68.8 kDa.
We initiated the expression analysis of mouse Kbtbd8
by RT-PCR using primers that can detect both predicted
transcripts and since we expected Kbtbd8 to be specific-
ally expressed in pluripotent stem cells, we started with
the analysis of organs and different pluripotent stem
cells. Indeed, we could find the expected two transcripts
in tissues (testis, muscle) and cell lines (ESC, maGSC,
iPSC, F9) (Additional file 1: Figure S1). We further ana-
lyzed the level of Kbtbd8 expression by qRT-PCR
(Figure 2B + D) and because an antibody was available
(Abcam, ab103727) we proceeded the expression studiesFigure 2 Quantitative expression of KBTBD8 on mouse tissues and ce
specific antibody revealed a high protein expression of KBTBD8 in different
ESCs. However, in maGSCs no KBTBD8 protein could be detected. α-Tubuli
Blot results. C: Western Blot analysis on different mouse organs revealed an
control. D: qRT-PCR results support the Western Blot results. Abbreviations:
Cells; maGSC: multipotent adult Germline Stem Cell; maGSCdiff.: differentiaby Western Blot analysis (Figure 2A + C). Kbtbd8 mRNA
expression could be detected in all tested cell lines and
organs. However, KBTBD8 protein could be only
detected in cells and organs which showed a high
mRNA expression level. The second predicted isoform
of the KBTBD8 protein could not be detected. Neverthe-
less, expression analysis on RNA as well as on protein
level in mouse tissues and cell lines revealed an ubiqui-
tous expression of KBTBD8. This result could be sup-
ported by RT-PCR on selected human tissues and cell
lines (Additional file 2: Figure S2A) where the predicted
transcript could be found in most of the tested samples.
To test the specificity of the antibody before starting
deeper analysis, we performed siRNA mediated down-
regulation of Kbtbd8 in NIH3T3 cells. Analysis of the
mRNA level revealed a downregulation up to 60%
resulting in a clear reduction of the protein as shown by
Western Blot analysis (Figure 3A + B). Immunocyto-
chemical analysis of siRNA transfected cells revealed a
shift of the Golgi apparatus in the cells, where KBTBD8
was clearly downregulated or absent (Figure 3C).
Cellular localization of mouse and human KBTBD8
To elucidate the cellular compartment in which KBTBD8
is localized, we performed immunocytochemical analysis.
The staining showed a typical perinuclear staining which
encouraged us to hypothesize that KBTBD8 is either local-
ized in the endoplasmic reticulum (ER) or in the Golgi ap-
paratus. We started with GM130 staining, as this protein is
a well known marker for the Golgi complex [21], and in-
deed could show, that KBTBD8 colocalize with GM130 inll lines. A: Western Blot analysis on mouse cell lines using a Kbtbd8
iated ESCs and maGSCs as well as in NIH3T3 cells and a low one in
n served as loading control. B: qRT-PCR results support the Western
ubiquitous expression in all tested organs. β-Actin served as loading
ESC: Embryonic Stem Cell; ESCdiff.: differentiated Embryonic Stem
ted multipotent adult Germline Stem Cell.
Figure 3 Altered KBTBD8 expression results in the dislocation of Golgi structures. To test the specificity of the KBTBD8 antibody and to
see, if there is an effect on the Golgi apparatus, NIH3T3 cells where transfected with siRNA against Kbtbd8. A: qRT-PCR results followed by
statistical analysis using t-test revealed the significant downregulation of Kbtbd8 mRNA in two biological replicates. B: Western Blot results
support the downregulation of KBTBD8 even on the protein level. C: Immunocytochemistry using GM130 and KBTBD8 specific antibodies
revealed an altered localisation of the Golgi matrix protein GM130. In cells, were KBTBD8 expression is downregulated or absent upon siRNA
transfections, the localization of the GM130 signal becomes rearranged (white arrows).
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confirmed in human fibroblasts as well (Figure 5A). To
further confirm the Golgi apparatus as the compartment in
which KBTBD8 is localized, we used two other Golgi
specific markers (58 K and Golgin97) for co-staining(Figure 5B +C) and again could identify the Golgi as the
subcellular localization of our protein. As it was obvious
that the percentage of overlapping staining was not 100%
we quantified the areas of co-staining by LSM software
and found a co-staining for KBTBD8 and GM130 in
Figure 4 Localization of KBTBD8 protein in NIH3T3 cell and after treatment with BFA or Nocodazole. NIH3T3 cells – with and without
BFA or Nocodazole treatment - were fixed and co-stained with KBTBD8 antibody and Golgi matrix marker GM130 or microtubule marker protein
α-Tubulin. Treatment with Brefeldin A (BFA) resulted in resorption of the Golgi membrane and Golgi marker proteins to the ER. For GM130 the
expected punctuated cytoplasmic localization could be found indicating that the treatment worked. However, KBTBD8 was either no longer
detectable, not co-localizing with GM130 or associated to the spindle apparatus of mitotic cells. Co-staining with α-Tubulin and Kbtbd8 in untreated cells
showed no localisation of KBTBD8 at the cytoskeleton. After Nocodazole- treatment, which results in the depolarisation of microtubules and in the
disperse of the Golgi stacks to the cytoplasm, GM130 and α-Tubulin showed the expected localisation whereas KBTBD8 was again either not detectable
at all or no longer co-localizing with GM130. These results indicate that KBTBD8 is not a part of the Golgi matrix. Scale bar, 10 μm.
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Golgin97 in 28,7% of the Golgi stackles. This result leads
us to hypothesize that KBTBD8 is not associated to the
Golgi membranes as it is known for GM130, 58 K and
Golgin97. To clarify the localization within the Golgi com-
plex, we next treated NIH3T3 cells with Brefeldin A (BFA)
and Nocodazole. BFA is a fungal antibiotic that reversibly
blocks the protein transport from the ER to the Golgi [22]
and therefore causes a collapse of the Golgi stacks. In con-
sequence of BFA treatment, the Golgi membranes and
marker enzymes are redistributed back to the ER, coat pro-
teins to the cytoplasm and Golgi matrix associated proteins
to Golgi debris as well as ER exit sites [23]. Therefore, BFA
treatment of cells results in a punctuated arrangement of
Golgi fragments that can be shown by GM130 staining.
Nocodazole promotes the depolymerisation of microtubuli.
As the perinuclear localization of the Golgi apparatus is
due to dynamic but not stable microtubules, the treatment
with Nocodazole leads to a disruption of the Golgi struc-
ture and therefore to the distribution of Golgi ministacks
throughout the cytoplasm [24]. Treatment of NIH3T3 cells
with both, BFA and Nocodazole, resulted in the expected
punctuated dispersion of GM130 (Figure 4), but KBTBD8relocation upon treatment did not follow a typical pattern
for Golgi-resident proteins. In both, BFA and Nocodazole
treated fibroblasts, KBTBD8 was either distributed all over
the cells without preferred colocalization with GM130 or
not detectable at all or localized at the spindle apparatus of
mitotic cells. This results suggest that KBTBD8 is not a
Golgi matrix protein and shows no direct interaction to
microtubules. Furthermore a co-staining of KBTBD8 and
α-tubulin showed no co-localization in non-dividing cells
suggesting the specificity of co-localisation for dividing
cells. However, to clarify whether the specific staining pat-
tern at the spindle apparatus of mitotic cells seen in BFA
treated cells is due to the treatment, we repeated the ex-
periment with serum starvation synchronized NIH3T3
cells and indeed could find the specific staining at the spin-
dle of dividing cells in all mitotic stages (Figure 6) revealing
that the spindle associated localization is indeed specific
for dividing cells.
Discussion
Proteins of the BTB-kelch family are known to be in-
volved in multiple biological processes such as migration,
cytoskeleton arrangement, regulation of cell morphology,
Figure 5 Co-localization of KBTBD8 and GM130, 58 K and Golgin97. BJ cells were fixed and co-stained with KBTBD8 antibody and the Golgi
markers GM130 (A), 58 K (B) or Golgin97 (C). Overlapping of the two fluorescence pictures was analyzed using the Fluoview Software driving the
CONFOCAL LASER SCANNING BIOLOGICAL MICROSCOPE (Olympus). A: Co-staining of KBTBD8 and GM130 showed a 34.4% co-localisation. B: Co-staining
of KBTBD8 and 58 K showed a 20.4% co-localisation. C: Co-staining of KBTBD8 and Golgin97 showed a 28.7% co-localisation. Scale bars as indicated.
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prediction about the function of a new member of this
family is difficult. Here we describe a novel BTB-kelch pro-
tein, KBTBD8 that is highly conserved from mouse to hu-
man. We report that 1) Kbtbd8 is ubiquitiously expressed;
2) KBTBD8 is a novel protein of the BTB-kelch family that
is located in the Golgi apparatus; 3) KBTBD8 is not a
Golgi-resident protein and 4) KBTBD8 is the first BTB-
kelch protein that localizes on the spindle apparatus upon
mitosis in proliferating cells.
There are many BTB-subfamilies known that are dis-
tributed through species but the quantity of families and
their members varies between species (reviewed in [6]).
Whereas for Saccharomyces cerevisiae there are onlyfour subfamilies with six proteins known, Drosophila
melanogaster already harbours eight subfamilies with 85
proteins. Mus musculus and Homo sapiens have the
same eight subfamilies with 194 and 183 total proteins,
respectively. The subfamilies are known as BTB only,
T1-Kv, ElonginC, Skp1, MATH-BTB, other architec-
tures, BTB-ZF and BBK whereas the last two resemble
the largest groups with more than 40 proteins in mouse
and human.
BTB-ZF (BTB-Zinc finger) proteins are also known as
POK (POZ and Krüppel zinc finger) proteins [6]. As
expected for zinc finger proteins, many members of this
family were characterized as transcription factors. The
BTB- domain in these proteins is responsible for
Figure 6 KBTBD8 is associated with the spindle apparatus in dividing cells. Proliferating NIH3T3 cells were fixed and co-stained with anti-KBTBD8
and anti- α-Tubulin antibodies. KBTBD8 seems to be released from the Golgi stackles with the onset of mitosis and co-localizes with α-Tubulin even
though the fibres of the spindle apparatus are not so obvious.
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tions whereas the ZFs are responsible for DNA binding.
The BBK (or BTB-BACK-kelch) family resembles the
second large group within the BTB proteins. The archi-
tecture of these proteins, the BTB/POZ domain together
with the BACK domain at the N-terminal part of the
proteins and the kelch-repeats at the C-terminal part of
the proteins, allows on the one hand the dimerization
via the BTB domain and on the other hand the associ-
ation to cytoskeleton via their kelch-repeat domain,
which is known for many BBK proteins [5]. As Kbtbd8
belongs to this family and we could observe faint cyto-
skeleton staining in rare cases, we co-stained with tubu-
lin (Figure 4) in Nocodazole treated and untreated cells
but could not confirm this assumption. Therefore,
Kbtbd8 seems not to be associated to the cytoskeleton.
In non-dividing cells, the Golgi apparatus is located at
the periphery of the nucleus, close to the ER. During cell
division the Golgi needs to be segregated and distributed
to the two daughter cells. With the onset of mitosis, the
Golgi complex become fragmented and disperses
throughout the cell. The Golgi matrix associated pro-
teins like GM130 mark this dispersion and can be found
as punctuated structures throughout the cytoplasm.
Treatment of cells with Brefeldin A (BFA) has the same
effect: it blocks the protein transport from the ER to the
Golgi [22] and therefore causes a collapse of the Golgi
stacks resulting in punctuated structures. Furthermore it
was shown that treatment with BFA had no effect on
partitioning of Golgi matrix proteins during mitosis.
GM130 positive matrix fragment become associated with
the forming spindle poles in pro- and metaphase stages.
In anaphase cells, these fragments were found to move
with the separating sister chromatids and end up on
both sides of each new-forming nucleus [25]. Further-
more, it was shown that the spindle plays a direct role in
the inheritance of the Golgi [26].
To our knowledge there is only one other BTB-kelch
protein known, that shows the golgi compartment as its
subcellular localization: “leucin zipper-like transcrip-
tional regulator 1” (LZTR-1). Nacak et al. [20] character-
ized LZTR-1 and could show a Golgi matrix associated
behaviour of LZTR-1 upon BFA treatment and therefore
conclude that LZTR-1 is, as GM130, a golgi matrix pro-
tein. They further analyzed the domains concerning their
function and could show that the BTB domain is re-
sponsible for the localization in the golgi apparatus.
Since KBTBD8 shows a different behaviour upon BFA
treatment than GM130, we conclude that KBTBD8 is
not a matrix associated Golgi protein but trapped in the
lumen. These results fit to the observation that KBTBD8
does not show a 100% co-localisation with GM130, 58 K
and Golgin97. Upon dissociation of the Golgi complex
during the entry into mitosis, KBTBD8 seems to bereleased and translocated to the spindle apparatus as we
could show by co-staining with α-tubulin on mitotic cells.
Although there is no protein from the BTB-kelch fam-
ily known that shows a connection between the Golgi
complex and the microtubule network, other proteins
have been shown to be associated with both, the cyto-
skeleton – either actin filaments or microtubules - and
the Golgi. These proteins include members of the Hook
families [27], cytoplasmic linker proteins (CLIPs) [28],
and plakins [29]. The Microtubule actin crosslinking fac-
tor 1b (MACF1b) was shown to be a linker protein be-
tween the actin filaments and the microtubules.
However, MACF1b is - despite its localization to the
cytoskeleton – mainly located in the Golgi and it could
be shown that the altered expression of MACF1b medi-
ated by RNA interference resulted in the dispersal of the
Golgi complex. A similar dislocation of Golgi structures
could be also seen by KBTBD8 downregulation. These
results lead us to suggest that KBTBD8 plays an import-
ant role in the maintenance of the Golgi structure.
Whether altered KBTBD8 expression will also affect the
mitotic spindle, needs to be elucidated in the future.Conclusion and outlook
KBTBD8 is the first described BBK protein that is located
in the Golgi apparatus and translocates to the forming
spindle upon entry into mitosis. The localization pattern
led us to hypothesize that it plays a role in golgi/mitotic
functions. Further studies will be performed in the future
to elucidate, whether Kbtbd8 has an influence on prolifera-
tion/ cell cycle by effecting the configuration of the spindle
apparatus. For LZTR-1 it was shown that the BTB/POZ
domain is responsible for the Golgi localization [20].
Therefore we suggest that it is also true for Kbtbd8. This
assumption has to be investigated and confirmed in future
experiments and would mean that there is a new unknown
role for the BTB domain besides di- and oligomerisation,
namely the localization within the Golgi apparatus.Material and methods
Cell lines, cell culture and BFA treatment
Human skin fibroblast cell line BJ was purchased from
Stemgent (Cambridge, USA). NIH3T3 cells and BJ cells
were cultured in standard fibroblast medium consisting of
DMEM supplemented with 10% FBS and 1% pen/strep.
Brefeldin A was purchased from AppliChem (Darmstadt,
Germany). BFA was dissolved in EtOH and used at a final
concentration of 1 μg/ml. Incubation with BFA containing
medium was carried out for 60 min. Nocodazole was
purchased from Sigma-Aldrich (Deisenhofen, Germany).
Nocodazole was dissolved in DMSO and used at a final
concentration of 10 μM for 2 h. Cells were than directly
fixed and used for immunofluorescence staining.
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Cells were fixed with 4% paraformaldehyde (PFA) in PBS
(pH 7.4) for 10–15 min at room temperature. Fixed cells
were permeabilized with 0.1% Triton X-100 for 5 min
and than blocked with 1% BSA (Sigma-Aldrich, St. Louis,
USA)/PBS-buffer for at least 1 h before being incubated
overnight with the appropriate primary antibodies
specific for GM130 (BD Laboratories), 58 K (Abcam),
Golgin97 (Molecular Probes, kindly provided by Prof. S.
Hoyer-Fender, Göttingen), Kbtbd8 (Abcam) or α-Tubulin
(Sigma-Aldrich).
Cells were rinsed three times and incubated in the ap-
propriate Cy3-or Alexa488-conjugated secondary anti-
body (Sigma, Invitrogen, respectively). For negative
control, cells were incubated with IgG as first antibody.
All incubations were performed in PBS (pH 7.4) with 5%
BSA and 0.1% Triton X-100. For nuclear staining, fixed
cells were imbedded with DAPI (40, 60-diamidino-2-
phenylindole) (SIGMA) dye. Microscopy was performed
on an Olympus confocal laser scanning microscope
(LSM). Pictures were taken as individual confocal stacks.
Origin of cells and tissues used in Western Blot and
RT-PCR analysis
Mouse organs were taken from animals according to
national regulations for the Care and Use of Labora-
tory Animals (similar to the U.S. National Research
Council guidelines). Isolation and origin of ESC and
maGSC cell lines was described previously [30]. iPSCs
were a kind gift of Rudolf Jaenisch [31]. F9, NIH3T3,
Hela and MDA-MB 231 were purchased from ATCC
(LGC Standards, Wesel, Germany). MEFs (mouse em-
bryonic fibroblasts) were isolated according to standard
mouse ESC culture conditions. RNA from human tis-
sues was purchased from BD Bioscience CLONTECH
(Human Total RNA Master Panel II) and used directly
for cDNA synthesis.
Isolation of proteins and Western Blot
Cells or tissues were resuspended in lysis buffer (10 mM
Tris/HCl, pH 8, 1 mM EDTA, 2.5% SDS) supplemented
with 1 mM phenylmethanesulphonylfluoride (PMSF)
and protease inhibitors and than sonicated. Protein ex-
tracts (20 μg) were denaturized at 70°C in NuPage SDS
sample buffer (Invitrogen), separated on a NuPage 10%
Bis-Tris Gel (Invitrogen) and transferred to a Hybond-C
Extra membrane (GE Healthcare Europe). Blots were
blocked for unspecific binding with 5% nonfat dry milk in
blocking buffer (25 mM Tris, 0.15 M NaCl, 0.1% Tween20)
and were incubated overnight at 4°C with primary and -
after washing in blocking buffer for 1 h at 4°C - with
secondary HRP-conjugated antibody. Protein bands were
visualised using enhanced chemiluminescence as described
by the manufacturer (Santa Cruz Biotechnology).RNA isolation and RT-PCR
Total RNA was extracted from cells or tissues by using
NucleoSpinW RNA II (Macherey & Nagel) according to
manufacturer’s protocol. Prior to reverse transcription
using Superscript II cDNA synthesis kit and oligo(dT)
primer (Invitrogen), RNA was treated with DNase I
(Sigma) to avoid any genomic DNA contamination. RT-
PCR amplification was performed by using specific
primers for mouse and human Kbtbd8, mouse HPRT
and human TBP. RT-PCR was done with 30–33 cycles
of 94°C, 30 s; 50°C–62°C, 30 s; 72°C, 45 s, depending on
the primer sets. Primersequences: mKbtbd8 (F: 50-CGC
AAT GAC ATT TCC TCT TT-30; R: 50-GGA AGG AAT
TTG GAA GAT GCT-30); mHPRT (F: 50-CGT CGT
GAT TAG CGA TGA TG-30;R: 50-TAT GTC CCC CGT
TGA CTG AT-30); hKbtbd8 (F:50-ATG GGA TTC CAT
CTT CAG ACC-30; R: 50-TTT CTG TAA GGC CGC
TAG TGA-30); hTBP (F: 50-AGC CTG CCA CCT TAC
GCT CAG-30; R: 50-TGC TGC CTT TGT TGC TCT
TCC-30).Quantitative RealTime-PCR (qRT-PCR)
RNA was isolated and treated as described in the former
section. Quantitative RealTime-PCR was performed on
ABI Prism 7900 HT Fast Detection System (Applied
Biosystems Inc.). Each 10 μl reaction was performed in
384-well format using SYBRgreen PCR Master Mix
(Qiagen) and 3 μM of each PCR primer. All reactions
were performed in triplicate on one plate and repeated
three times (technical replicates). For each experiment a
second biological replicate was performed to reach statis-
tical significance. Levels of mRNA expression were nor-
malized to those of the mouse housekeeping gene HPRT
(Hypoxanthine-guanine phosphoribosyltransferase). Oligo-
nucleotide primers for qRT-PCR were obtained from
Eurofins MWG Operon (Ebersberg, Germany). Primer se-
quences were as follows: qRT-HPRT (F: 50-AGC CCC
AAA ATG GTT AAG GTT GC-30; R: 50-TTG CAG ATT
CAA CTT GCG CTC AT-30); qRT-Kbtbd8 (F: 50-GCA
ATC AGC CCC TAC TTC -30; R: 50-CAC TGG TCT
TGTATG GAA GG-30).Transfection of NIH3T3 cells with siRNA
siRNA for mouse Kbtbd8 was purchased from SantaCruz
(sc-146354) and consists of a mixture of three different
siRNAs. All three siRNA duplexes target both transcripts.
Transient transfections of NIH3T3 cells were performed in
6-Well-Plates (Sarstedt) using ApplifectSI (AppliChem)
according to manufacturer’s instructions. In brief, 1.6×105
Cells were seeded per well and transfected using 180 pmol
of siRNA as recommended. Cells were harvested after 48 h
followed by both RNA and Protein isolation.
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Additional file 1: Figure S1. Genomic structure of mouse Kbtbd8.
A: Transcript 1 (T1) consists of 5 exons whereas the start codon is located
at the end of the short exon one. T2 consists of exon 3 and 4. The lack of
exons 1 and 2 result in a truncated BTB/POZ domain. B: RT-PCR analysis
on mouse pluripotent cell lines and mouse tissues revealed a ubiquitous
expression of both Kbtbd8 transcripts (arrow). HPRT served as loading
control. Abbreviations: ESC: Embryonic Stem Cell; maGSC: multipotent
adult Germline Stem Cell; iPSC: induced Pluripotent Stem Cell; F9: mouse
juvenile teratocarcinoma cell line.
Additional file 2: Figure S2. Expression analysis of KBTBD8 on human
tissues and cell lines. (A) RT-PCR analysis on human cell lines and tissues
revealed and ubiquitous expression of KBTBD8. TBP (TATA box binding
protein) served as loading control. hFB: human fibroblast cell line BJ. (B) BJ
cells were fixed and co-stained with KBTBD8 and GM130 or α-Tubulin
antibodies. It could be shown that the compartment in which KBTBD8 is
localized in human cells is the same as in mouse cells. Scale bars, 10μm.
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